India Policy Document

Guidelines for Evaluation of Nanopharmaceuticals in India

2017
Policy Type Regulation
Coverage Level National
Policy Sector Medicine
ELSA-HSE Issues Safety

PUBLISHER (s)

  • Indian Society of Nanomedicine